These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8251687)

  • 1. Stability of spironolactone in an extemporaneously prepared suspension at two temperatures.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1993 Oct; 27(10):1198-9. PubMed ID: 8251687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of extemporaneously compounded spironolactone suspensions.
    Mathur LK; Wickman A
    Am J Hosp Pharm; 1989 Oct; 46(10):2040-2. PubMed ID: 2816959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stability of cisapride in a liquid dosage form at two temperatures.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1995 Feb; 29(2):125-6. PubMed ID: 7756708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of pentoxifylline in an extemporaneously prepared oral suspension.
    Abdel-Rahman S; Nahata MC
    Am J Health Syst Pharm; 1997 Jun; 54(11):1301-3. PubMed ID: 9179352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of isradipine in an extemporaneously compounded oral liquid.
    MacDonald JL; Johnson CE; Jacobson P
    Am J Hosp Pharm; 1994 Oct; 51(19):2409-11. PubMed ID: 7847406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of amiodarone in an oral suspension stored under refrigeration and at room temperature.
    Nahata MC
    Ann Pharmacother; 1997; 31(7-8):851-2. PubMed ID: 9220043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt.
    Graves R; Phan KV; Bostanian LA; Mandal TK; Pramar YV
    Int J Pharm Compd; 2017; 21(4):334-338. PubMed ID: 28719376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability of flecainide acetate in an extemporaneously compounded oral suspension.
    Wiest DB; Garner SS; Pagacz LR; Zeigler V
    Am J Hosp Pharm; 1992 Jun; 49(6):1467-70. PubMed ID: 1529992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of 5-aminosalicylic acid suspension.
    Montgomery HA; Smith FM; Scott BE; White SJ; Gerald KB
    Am J Hosp Pharm; 1986 Jan; 43(1):118-20. PubMed ID: 3953581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of preparation method and storage on rifampin concentration in suspensions.
    Nahata MC; Morosco RS; Hipple TF
    Ann Pharmacother; 1994 Feb; 28(2):182-5. PubMed ID: 8173129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of itraconazole in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; Walters JR
    Am J Health Syst Pharm; 1995 Jan; 52(2):189-91. PubMed ID: 12879547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of sotalol in two liquid formulations at two temperatures.
    Nahata MC; Morosco RS
    Ann Pharmacother; 2003 Apr; 37(4):506-9. PubMed ID: 12659604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of acetazolamide in suspension compounded from tablets.
    Alexander KS; Haribhakti RP; Parker GA
    Am J Hosp Pharm; 1991 Jun; 48(6):1241-4. PubMed ID: 1858804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of terbinafine hydrochloride in an extemporaneously prepared oral suspension at 25 and 4 degrees C.
    Abdel-Rahman SM; Nahata MC
    Am J Health Syst Pharm; 1999 Feb; 56(3):243-5. PubMed ID: 10030510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of an extemporaneously compounded terbutaline sulfate oral liquid.
    Horner RK; Johnson CE
    Am J Hosp Pharm; 1991 Feb; 48(2):293-5. PubMed ID: 2003504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability of norfloxacin in an extemporaneously prepared oral liquid.
    Johnson CE; Price J; Hession JM
    Am J Health Syst Pharm; 2001 Apr; 58(7):577-9. PubMed ID: 11296605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of ketoconazole, metolazone, metronidazole, procainamide hydrochloride, and spironolactone in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Sep; 53(17):2073-8. PubMed ID: 8870895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.